Ingka Group (IKEA) Global Partnership and Specialty Retail Wins Signal Growing Demand for Unified Omnichannel Fulfillment As retailers gather at NRF 2026 to navigate growing complexity across omnichannel fulfillment, inventory optimization, and store operations, Made4net, a global leader in WMS (warehouse management system) and supply chain execution software, enters the event with strong retail momentum–driven […]
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Jan. 2, 2026, the company approved 300 restricted stock units (“RSUs”), each representing the right to receive one share of its common stock upon vesting, to a new non-executive employee. The award was made pursuant to the Nasdaq inducement grant exception as a component of the
Veteran genomics leader joins Illumina to advance global medical strategy Illumina chief commercial officer to depart for role as a life science tools company CEO Today, Illumina, Inc. (NASDAQ: ILMN) announced the appointment of Eric D. Green, M.D., Ph.D., as Chief Medical Officer (CMO), effective February 2. In this role reporting to the CEO, Dr.
(NASDAQ:AIRE), DUBLIN, Ohio, Jan. 08, 2026 (GLOBE NEWSWIRE) — reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company” or “reAlpha”), an AI-powered real estate technology company, today announced that it will host a live, audio-only X Spaces session titled “AIRE Time with Mike & Vijay” on Tuesday, January 13, 2026, at 12:00 P.M. ET. The session will
(NASDAQ:NAVI), HERNDON, Va., Jan. 08, 2026 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI) announced today the following changes in its leadership structure to better align with its business strategy. Steve Hauber, EVP and chief administrative officer (CAO), has been appointed EVP and chief financial officer (CFO), effective immediately. He is now responsible for Navient's finance and
(Euronext Growth Paris:ALCLS),(NasdaqGM:CLLS), NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today outlined its strategic priorities and key catalysts expected for 2026. “2025 was a transformational year for Cellectis,
(NYSE:EBS), GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) — Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to supply BioThrax(R) (Anthrax Vaccine Adsorbed) in 2026. This order is under Emergent's existing indefinite-delivery/indefinite-quantity (IDIQ) contract (W911SR24D0001), led by the Capability
Kimbell Royalty Partners, LP (NYSE: KRP) (“Kimbell”), a leading owner of oil and natural gas mineral and royalty interests in more than 131,000 gross wells across 28 states, today announced that it will release its fourth quarter 2025 financial results on Thursday, February 26, 2026, before the market opens. Kimbell will also declare its fourth
(NYSE:CPA), PANAMA CITY, Jan. 08, 2026 (GLOBE NEWSWIRE) — Copa Holdings, S.A. (NYSE: CPA) announces the following events: Earnings Release – Fourth Quarter 2025 Date: February 11, 2026 Time: After US market close This release will be available on our website: ir.copaair.com/financial-information/quarterly-results Earnings Conference Call and Webcast Date: February 12, 2026 Time: 11:00 AM US
(NASDAQ:VRSK), Jersey City, NJ, Jan. 08, 2026 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, today announced it has sold Verisk Marketing Solutions (VMS) to ActiveProspect, the leading consent-based marketing platform. VMS, part of Verisk's underwriting division, provides leading marketing solutions for customers in